QUOTED. 27 August 2019. Thierry Herbreteau.
Executive Summary
Peters Surgical CEO Thierry Herbreteau says big medtech firms will likely be able to cope with the implementation of the EU's new Medical Device Regulation (MDR). Rather, he's worried about how start-up companies will fare. See what Herbreteau said here.
"For start-ups, it’s a disaster." – Thierry Herbreteau, CEO, Peters Surgical
- Find out more: German Industry Says MDR Implementation 'Too Slow' But Negative Economic Effects Still Largely Unreported
Click here for a free trial of Medtech Insight